Brisbane healthtech startup DoseMe receives $2.6 million in Series A funding to commercialise drug dosage tool

Brisbane healthtech startup The investment, which comes after $500,000 in seed funding from Steve Baxter in 2014, will help DoseMe commercialise into the Australian market and also expand into the US. As part of the funding, Spurgin will be joining Baxter, CEO Charles Cornish, and founder Robert McLeay on the startup’s board.